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Congenital Goitrous Hypothyroidism, Deafness and
Iodide Organification Defect in Four Siblings: 
Pendred or Pseudo-Pendred Syndrome?
Case Report
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Introduction
Pendred syndrome (PDS) is an autosomal recessive 
disorder first described in 1896 as a combination of 
congenital deafness and goiter (1). The iodide organification
defect in PDS was revealed by perchlorate discharge test in
1958 (2). Despite the impaired iodide organification, most 
individuals with PDS are clinically and biochemically 
euthyroid  (3). However, mild hypothyroidism may occur 
during childhood (4). The deafness in PDS is not caused by
hypothyroidism  (3), and is associated with inner ear 
abnormalities ranging from an isolated enlarged vestibular
aqueduct to a cochlear malformation known as Mondini
dysplasia (5,6). These malformations of the inner ear that
are essential for the diagnosis of true PDS can be detected
by high-resolution computed tomography (CT) or magnetic
resonance imaging (MRI) (7,8).
The gene, being referred as PDS or SLC26A4, has been
mapped to chromosome 7q in 1996 and encodes pendrin
protein that functions as a transmembrane anion transporter
in the thyroid and in the inner ear (9,10). To date, more than
100 mutations of the PDS gene have been shown to be 
associated with PDS (11). However, it has been recently 
demonstrated that some families with features of PDS do
not have the inner ear malformations or mutations in the
PDS gene. This condition has been named as “pseudo-
Pendred syndrome” (pseudo-PDS), and has been hypothesized
to be of autoimmune origin (12,13). On the other hand, 
some case reports have shown an association between
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deafness with mutations in the thyroid peroxidase (TPO)
gene (14,15). Accordingly, a TPO defect along with hearing
impairment might be considered in the etiology of 
pseudo-PDS.
Here we report four siblings who have goiter, severe
hypothyroidism, positive perchlorate test and sensorineural
deafness, but not the inner ear abnormality which is diag-
nostic for PDS. 
Case Report
Four siblings presented with main complaints of short
stature and deaf-mutism at ages ranging between 10.5 and
17.3 yrs (Figure 1). Their parents were cousins, and had no
signs of hypothyroidism, goiter or hearing loss. Besides
congenital deafness, the patients had mental and 
developmental delay. We could not measure their mental
levels, because they could not speak. Their growth had 
also been retarded since birth. On physical examination, all
four children had multinodular goiter and severe short 
stature. Their height SD scores were between -5.1 SD and
-7.3 SD, and their bone ages were severely retarded. The
clinical and laboratory data of the siblings are summarized in
Table 1.
Ultrasound findings, which were similar in all siblings,
consisted of enlarged thyroid glands (volumes ranging from
12 ml to 42 ml) with multiple milimetric nodules and normal
echo patterns. Free thyroxine (fT4) and thyrotropin (TSH) 
levels were compatible with severe hypothyroidism 
(Table 1). Anti-TPO and anti-thyroglobulin antibodies were
negative in all siblings. The perchlorate tests, performed in
three of the patients showed 131I discharges ranging 
between 51.9% and 75.0% (normal <10%), indicating the
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Figure 1. Four siblings with severe short stature caused by 
congenital goitrous hypothyroidism
Table 1. Clinical and laboratory data of the siblings 
Parameters Patient No
I II III IV
Sex Male Male Female Male
Age (years)  17.3 16.0 13.1 10.6
Height (cm) 136.0 127.6 111.4 101.3
Height SDS - 5.9 - 6.3 - 7.5 - 5.1
Bone age (years) 4.5 3.0 2.5 2.0
Goiter Multinodular Multinodular Multinodular Multinodular
Thyroid volumes (ml)* 37.2 27.8 42.0 12.0
(Normal values for age) (11.9±1.7) (11.9±1.7) (8.9±2.5) (4.9±1.6)
f T4 ng/dl (N: 0.89-1.80) 0.10 0.12 0.24 0.26
TSH μIU/ml (N: 0.35-5.50) >800 >800 158 136
Perchlorate test (N <10 %) 75 51.9 61.4 ND
Anti-thyroid antibodies Negative Negative Negative Negative
Sensorineural hearing loss Profound Profound Profound Profound
Left/Right ears PTA (dB)** 85/95 82/83 85/80 92/88
HR-CT of the temporal bones Normal Normal Normal Normal
*Thyroid volumes determined by ultrasonography
**PTA > 80 dB indicates profound hearing loss. 
SDS: standard deviation score, PTA: pure-tone audiometry, fT4: free thyroxine, TSH: thyrotropin
HR-CT: high-resolution computed tomography, ND: Not done
140 cmcomplete defect in iodide organification into thyroglobulin.
L-thyroxine replacement therapy was initiated to treat the
congenital goitrous hypothyroidism caused by iodide 
organification defect. 
Audiological examination revealed bilateral profound
sensorineural hearing loss (pure tone audiometry >80 dB) in
all four siblings. However, high-resolution CT of the 
temporal bones of the siblings did not show any cochlear
malformation, such as enlarged vestibular aqueducts and
dilated endolymphatic sacs, which are almost specific for
PDS and prerequisite for its diagnosis. At this stage, we 
decided to perform a molecular genetic analysis for definite
diagnosis, which could not be performed due to the 
unwillingness of the parents to give us permission to 
analyze the TPO and PDS genes. The family also failed to
bring their children for follow-up. 
Discussion
According to the Fraser criteria (16), which include 
congenital deafness, goiter and a positive perchlorate 
discharge test, at first glance, our patients appear to be 
cases of PDS. However, some authors have advocated that
inner ear abnormalities must be included as an essential
prerequisite for the diagnosis (8,17). Although a Mondini
malformation of the cochlea was present only in a minority
of patients (5), the enlargement of the endolymphatic duct
and sac, and of the vestibular aqueduct have been 
documented by high-resolution CT and MRI in 80-100% of
patients with PDS (7,8). Fugazzola et al (12) studied the
PDS gene mutations in nine patients from six families with
a clinical diagnosis of PDS based on sensorineural hearing
loss, multinodular goiter and a positive perchlorate test.
They found that all seven patients, who were homozygous
or compound heterozygous for PDS mutations, had the 
inner ear malformations detected by high-resolution CT or
MRI; but, interestingly, the inner ear structures were 
normal in two sisters without mutations. The latter patients
were referred to as pseudo-PDS by the authors. This 
important study has demonstrated that the differential 
diagnosis between PDS and pseudo-PDS should be based
on the presence of inner ear malformations and, of course,
of PDS gene mutations. Unfortunately, we could not do a
molecular analysis. Yet, we performed high-resolution CT of
temporal bones, but did not detect any inner ear 
abnormality in any of the four siblings. Thus, the finding of
a normal inner ear was consistent with the diagnosis of
pseudo-PDS, and not with that of PDS. 
Moreover, while most cases of PDS are euthyroid, our
patients had severe congenital hypothyroidism (CH) 
causing mental retardation, severe short stature, and 
remarkably delayed bone age. Some patients are reported
to have subclinical or mild hypothyroidism that usually 
appears after mid-childhood (3,4,16-18). But one can still
consider that these siblings are extremely rare examples of
PDS manifested as severe CH. Reviewing the literature we
found only one study on genetically confirmed PDS among
patients with CH (19). In that study, out of 197 children with
neonatal screening-detected CH, three fulfilled the clinical
diagnostic criteria of PDS, and only two had the PDS gene
mutations. Interestingly, these two true PDS patients had
been diagnosed at birth as cases of subclinical and mild
hypothyroidism, while a pseudo-PDS patient had presented
with more severe CH (TSH: 150 mIU/L and T4: 1.16 μg/dl).
This study indicates that PDS is a rare cause of CH, and 
also that PDS patients are mildly affected by CH. Therefore,
since the severe state of hypothyroidism in our patients
was not compatible with a diagnosis of PDS, we speculated
that the condition in our patients should be explained by a
reason other than PDS. 
In the study by Fugazolla et al (12), the patients with
PDS (age range:14-41 years) were identified to be cases of
subclinical hypothyroidism with normal fT4 and TSH values,
whereas two patients with a pseudo-PDS phenotype had
overt hypothyroidism, probably caused by an autoimmune
thyroid disease. Davis et al (13) reported dizygotic twins 
diagnosed to have sensorineural deafness and hypothyroidism
caused by autoantibodies against the inner ear and thyroid
tissues (anti-DEP-1/CD148 and anti-TPO, respectively), 
suggesting a link between autoimmune inner ear disease
and autoimmune thyroid disease. The authors suggest that
investigation for antibodies is warranted in children with
possible PDS who are negative for PDS gene mutations and
do not manifest the classical radiological findings. In addition,
the perchlorate test is not necessarily conclusive of PDS,
because positive results are reported in 20-80% of patients
with Hashimoto thyroiditis (20). In our patients, we
excluded the possibility of autoimmune damage to the
thyroid gland since the results of antibody tests were 
negative and ultrasound examination of the thyroid gland 
revealed normal results. 
In fact, the combination of CH, goiter and a positive 
perchlorate test indicating iodide organification defect should
first remind one of the possibility of dyshormonogenesis due to
a TPO defect (21). Although patients with TPO defect do
not usually have deafness, some cases with both TPO 
defect and hearing loss, have been reported (14,15). Pfarr
et al (15) described a child who was clinically diagnosed to
have PDS, but had only a monoallelic mutation in the PDS
gene and a functionally normal pendrin protein. This patient,
exhibiting a pseudo-PDS phenocopy, was compound 
heterozygous for mutations in the TPO gene. This study 
demonstrates that other genetic explanations for hearing
loss should be considered in pseudo-PDS patients, and the
TPO gene is the primary candidate gene in this instance.
Because congenital deafness is very common, affecting 
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found to be involved in it (22), the origin of hearing loss in
cases of pseudo-PDS may be due to mutations in other 
deafness genes.
In conclusion, although we were not able to confirm it
by molecular analysis, we clinically diagnosed four siblings
with congenital severe hypothyroidism due to impaired 
iodide organification and an accompanying congenital 
deafness owing to, probably, a TPO or other genetic defect.
We also speculate that our patients with goiter and hearing
loss may possibly be pseudo-PDS cases, because of their
structurally normal inner ears, and their clinically and 
biochemically severe hypothyroid state. To establish the 
clinical diagnosis of PDS, imaging studies of temporal 
bones are mandatory and must be performed before 
genetic analysis. If the inner ear structures are normal, the
patients should be initially investigated for anti-thyroid 
antibodies, and if required, for anti-cochlear antibodies. We
also suggest that the TPO gene should be analyzed in 
pseudo-PDS patients with congenital goitrous hypothyroidism
and deafness.
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